Direct comparison
IRB vs. IBC: What's the Difference?
IRB reviews human-subjects risk under the Common Rule; IBC reviews rDNA biosafety under NIH Guidelines. Compared side by side, plus when a study needs both.
Side-by-side comparison
| Dimension | IRB | IBC |
|---|---|---|
| What it protects | Rights and welfare of human research subjects | Lab workers, community, and environment from biohazards |
| Regulatory basis | Common Rule (45 CFR 46); 21 CFR Part 56 for FDA-regulated research | NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules |
| Administering federal office | HHS Office for Human Research Protections (OHRP); FDA for regulated products | NIH Office of Science Policy (OSP) |
| What triggers review | Research (45 CFR 46.102(l)) involving a human subject (45 CFR 46.102(e)) — both conditions required | Use of recombinant/synthetic nucleic acid molecules; most institutions also cover other biohazards by local policy |
| Minimum composition | Majority present at convened meeting, including at least one non-scientist member | At least 5 members with rDNA/containment expertise, including at least 2 unaffiliated community representatives |
| What approval authorizes | Enrollment of human subjects under an approved protocol and consent process | Specific biosafety-level (BSL) procedures under an approved risk-category review |
| Institution-wide trigger | Registration and FWA required per institution operating an IRB for covered research | Once any NIH funding applies to rDNA research, Guidelines apply institution-wide to ALL rDNA work regardless of individual project funding |
Common questions
FAQ
Can the same study need only one of the two committees?+
Yes. Most studies trigger only one — a survey study needs only IRB review, a non-human bench rDNA experiment needs only IBC review. Overlap arises only when a protocol independently meets both committees' triggers.
Does IBC review require the specific project to be NIH-funded?+
No. Once an institution receives any NIH funding for recombinant/synthetic nucleic acid molecule research, the NIH Guidelines and IBC review apply institution-wide to all such research, regardless of that project's own funding source.
Which committee assigns the biosafety level?+
The IBC, through risk-category review of the specific agent, procedure, and volume — not the IRB, even on studies that also require IRB approval.
